주메뉴 바로가기 본문 바로가기
  • KDCA
  • Contact us
  • E-Submission

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS. pISSN: 2210-9099. eISSN: 2233-6052
About
Browse articles
Editorial policies
For authors
Corrigendum

Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]

Osong Public Health and Research Perspectives 2020;11(3):146-146.
Published online: May 31, 2020

Korea Centers for Disease Control and Prevention, Cheongju, Korea

*Corresponding author: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention, Cheongju, Korea, E-mail: jeongek@korea.kr

Copyright ©2020, Korea Centers for Disease Control and Prevention

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

  • 9,167 Views
  • 110 Download
  • 4 Crossref
prev next
In the above-mentioned article, the authors want to update the errors in Results and Table 3, specifically the errors in the percentages and the subheadings with clearer meaning. The authors regret this error and would like to apologize for any inconvenience caused.
In the result section, “Of 63 cases, 96.8% were reported to have comorbidities: 47.6% hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases.” should be changed to: “Of 66 cases, 92.4% were reported to have comorbidities: 45.4% hypertension, 34.8% diabetes, 24.2% neurodegenerative disorders, and 16.7% pulmonary diseases”.
The results related to fatal cases in Table 3 should be changed as follows.
Table 3
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
Table 3
Variables n (%)
Age, years, median (range) 77 (35–93)

Sex
 Female 29 (43.9)
 Male 37 (56.1)

Coexisting condition*
 Any 61 (92.4)
  Cerebrovascular disease 5 (7.6)
  Heart disease 10 (15.2)
  Pulmonary disease 11 (16.7)
  Kidney disease 5 (7.6)
  Diabetes 23 (34.8)
  Hypertension 30 (45.4)
  Cancer 7 (10.6)
  Neurodegenerative disorder 16 (24.2)
 Under investigation 5 (7.6)

Region
 Daegu 47 (71.2)
 Gyeongbuk 16 (24.2)
 Others 3 (4.5)

Death before admission 5 (7.6)
Interval, days, median (range)
 Symptom → Death 10 (1–24)
 Symptom → Diagnosis 4 (0–20)
 Symptom → Hospitalization 4.5 (0–11)
 Hospitalization → Death 5 (0–16)

Total 66

*A single case may have multiple comorbidities (investigation files required).

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
Osong Public Health Res Perspect. 2020;11(3):146-146.   Published online June 1, 2020
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
Osong Public Health Res Perspect. 2020;11(3):146-146.   Published online June 1, 2020
Close
Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]

Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.

Variables n (%)
Age, years, median (range) 77 (35–93)

Sex
 Female 29 (43.9)
 Male 37 (56.1)

Coexisting condition*
 Any 61 (92.4)
  Cerebrovascular disease 5 (7.6)
  Heart disease 10 (15.2)
  Pulmonary disease 11 (16.7)
  Kidney disease 5 (7.6)
  Diabetes 23 (34.8)
  Hypertension 30 (45.4)
  Cancer 7 (10.6)
  Neurodegenerative disorder 16 (24.2)
 Under investigation 5 (7.6)

Region
 Daegu 47 (71.2)
 Gyeongbuk 16 (24.2)
 Others 3 (4.5)

Death before admission 5 (7.6)
Interval, days, median (range)
 Symptom → Death 10 (1–24)
 Symptom → Diagnosis 4 (0–20)
 Symptom → Hospitalization 4.5 (0–11)
 Hospitalization → Death 5 (0–16)

Total 66

*A single case may have multiple comorbidities (investigation files required).

Table 3 Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.

A single case may have multiple comorbidities (investigation files required).